Bausch + Lomb gets Health Canada approval for Lumify
VAUGHAN, Ontario — Bausch + Lomb Corp. announced that Health Canada has approved Lumify (brimonidine tartrate ophthalmic solution 0.025% w/v), the first and only over-the-counter eye drop developed with low-dose brimonidine tartrate to relieve redness of the eye due to minor eye irritations for adults. “With Health Canada’s approval of LUMIFY, we are excited to